Page 8 of 14 – SEC Filing CUSIP No. 761299106
Item 1. (a). Name of Issuer: Retrophin, Inc.
(b). Address of Issuer’s Principal Executive Offices: 1255 El Camino
Real, Suite 250 San Diego, CA 92130
Item 2. (a). Name of Person Filing: Scopia Capital Management LP Scopia Management, Inc. Scopia Windmill
Fund LP Scopia Capital GP LLC Matthew Sirovich Jeremy Mindich
(b). Address or Principal Business Office or, if None, Residence: Scopia Capital Management LP 152 West 57th Street, 33rd Floor New York, NY 10019 Scopia Management, Inc. Scopia Windmill Fund LP Scopia Capital GP LLC Matthew Sirovich Jeremy Mindich c/o Scopia Capital Management LP 152 West 57th Street, 33rd Floor New York, NY 10019
(c). Citizenship: Scopia Capital Management LP – Delaware limited partnership Scopia Management, Inc. – New York corporation Scopia Windmill
Fund LP – Delaware limited partnership Scopia Capital GP LLC – Delaware limited liability company Matthew Sirovich – United States citizen Jeremy Mindich
– United States citizen
(d). Title of Class of Securities: Common Stock, par
value $0.0001 per share
(e). CUSIP Number: 761299106
Item 3. If this statement is filed pursuant to §§.240.13d-1(b) or 240.13d-2(b), or (c), check whether the person filing is a:
(a) [_] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). (b) [_] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). (c) [_] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). (d) [_] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). (e) [_] An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E); (f) [_] An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F); (g) [_] A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G); (h) [_] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C.1813); (i) [_] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) [_] A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J); (k) [_] Group, in accordance with §240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution:
Follow Travere Therapeutics Inc. (NASDAQ:TVTX)
Follow Travere Therapeutics Inc. (NASDAQ:TVTX)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
| CUSIP No. | 761299106 |
| Item 1. | (a). | Name of Issuer: | |
| Retrophin, Inc. |
| (b). | Address of Issuer’s Principal Executive Offices: | ||
| 1255 El Camino Real, Suite 250 San Diego, CA 92130 |
| Item 2. | (a). | Name of Person Filing: | |
| Scopia Capital Management LP Scopia Management, Inc. Scopia Windmill Fund LP Scopia Capital GP LLC Matthew Sirovich Jeremy Mindich |
| (b). | Address or Principal Business Office or, if None, Residence: | ||
| Scopia Capital Management LP 152 West 57th Street, 33rd Floor New York, NY 10019 Scopia Management, Inc. Scopia Windmill Fund LP Scopia Capital GP LLC Matthew Sirovich Jeremy Mindich c/o Scopia Capital Management LP 152 West 57th Street, 33rd Floor New York, NY 10019 |
| (c). | Citizenship: | ||
| Scopia Capital Management LP – Delaware limited partnership Scopia Management, Inc. – New York corporation Scopia Windmill Fund LP – Delaware limited partnership Scopia Capital GP LLC – Delaware limited liability company Matthew Sirovich – United States citizen Jeremy Mindich – United States citizen |
| (d). | Title of Class of Securities: | ||
| Common Stock, par value $0.0001 per share |
| (e). | CUSIP Number: | ||
| 761299106 |
| Item 3. | If this statement is filed pursuant to §§.240.13d-1(b) or 240.13d-2(b), or (c), check whether the person filing is a: |
| (a) | [_] | Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). | |
| (b) | [_] | Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). | |
| (c) | [_] | Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). | |
| (d) | [_] | Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). | |
| (e) | [_] | An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E); | |
| (f) | [_] | An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F); | |
| (g) | [_] | A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G); | |
| (h) | [_] | A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C.1813); | |
| (i) | [_] | A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); | |
| (j) | [_] | A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J); | |
| (k) | [_] | Group, in accordance with §240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution: |
Follow Travere Therapeutics Inc. (NASDAQ:TVTX)
Follow Travere Therapeutics Inc. (NASDAQ:TVTX)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
